46 commercial payer policies list J0584. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
46 policies from 25 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Codes labeled “Inferred from policy title” are not listed in the policy document; Backwork attached them because the policy title names the drug.
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab-Twza Injection (Crysvita)Effective 05/01/2022 - 04/30/2023 | May 1, 2022 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Burosumab-Twza Injection (Crysvita)Effective 05/01/2023 - 03/31/2024 | May 1, 2023 | Prior auth requiredInferred from policy title |
| Burosumab-Twza Injection (Crysvita)Effective 07/01/2021 - 04/30/2022 | Jul 1, 2021 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Burosumab-Twza Injection (Crysvita)Effective 08/01/2019 - 07/31/2020 | Aug 1, 2019 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Burosumab-Twza Injection (Crysvita)Effective 08/01/2020 - 06/30/2021 | Aug 1, 2020 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Burosumab-Twza Injection (Crysvita)Effective 11/02/2018 - 07/31/2019 | Nov 2, 2018 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Crysvita (burosumab-twza) Non-oncology | Not recorded | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Crysvita (burosumab-twza) Non-OncologyEffective 04/01/2025 - 03/31/2026 | Not recorded | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Crysvita (burosumab-twza)Effective 04/01/2024 - 02/28/2025 | Apr 1, 2024 | Prior auth requiredInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
|---|
| Policy | Effective | Status of J0584 |
|---|---|---|
| Crysvita (Burosumab-Twza) | May 1, 2026 | Covered |
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Crysvita (Burosumab-Twza) – Commercial and Individual Exchange Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Crysvita (Burosumab-Twza) – Community Plan Medical Benefit Drug Policy | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab-twza (Crysvita) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Burosumab-twza (Crysvita) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab-twza | Oct 1, 2025 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab-twza | Oct 1, 2025 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab-twza | Oct 1, 2025 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab-twza | Oct 1, 2025 | Covered |
| Specialty Medication Administration Site of Care | Jan 1, 2026 | Covered |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Crysvita (burosumab-twza) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| State and School Employees' Health Insurance Plan - Crysvita (burosumab-twza) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab (Crysvita) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Burosumab (Crysvita) – Minnesota Health Care Programs | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab-twza (Crysvita) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Burosumab-twza (Crysvita) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Crysvita (burosumab-twza) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Crysvita (burosumab-twza) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Crysvita (Burosumab-Twza) | May 1, 2026 | Covered |
| Provider Administered Drugs – Site of Care | Oct 1, 2026 | Covered |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab-twza (e.g., Crysvita) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| CRYSVITA | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| CRYSVITA (BUROSUMAB-TWZA) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab Crysvita | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab-twza(Crysvita) | May 25, 2018 | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Cigna MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab-twza (Crysvita); CP.PHAR.11 | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Q4 - 2026 JHP MedOnc Master Drug List.pdf | Not recorded | Prior auth required |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Crysvita | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Burosumab-twza (Crysvita) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| 00633 burosumab-twza (Crysvita) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Crysvita (burosumab-twza) | Not recorded | Covered with conditionsInferred from policy title. Not listed in the policy document; attached because the policy title names the drug. |
| Policy | Effective | Status of J0584 |
|---|---|---|
| Crysvita (Burosumab-Twza) | May 1, 2026 | Covered |